Literature DB >> 25301295

Spectroscopic and DFT investigation of interactions between cyclophosphamide and aspirin with lysozyme as binary and ternary systems.

Mohammad Reza Bozorgmehr1, Jamshidkhan Chamani, Ghodsiye Moslehi.   

Abstract

Multi-spectroscopic and density functional theory (DFT) calculations was used to study the interaction between cyclophosphamide (CYP) and aspirin (ASA) with lysozyme (LYS). The experimental results showed that fluorescence quenching of LYS by drug was a result of the formation of drug-LYS complex; static quenching was confirmed to result in fluorescence quenching. Modified Stern-Volmer plots of interaction between CYP and ASA with protein in the binary and ternary systems were used to determine the binding parameters. Molecular distances between the donor (LYS) and acceptor (CYP and ASA) for all systems were estimated according to Forster's theory. The quantitative analysis obtained by CD spectra suggested that the presence of ASA and CYP decreased the α-helical content of LYS and induced the destabilizing of it. Theoretical studies on the interaction between LYS with ASA and CYP have been carried out using DFT at the B3LYP/6-31G level in the solvent phase. Binding energy of the mentioned complexes was calculated. It showed that tryptophan (Trp) 62 had the most affinity toward ASA and CYP. Analyzing the calculated results revealed that the five member ring of Trp has a key role in interaction of LYS with ASA and CYP.

Entities:  

Keywords:  aspirin; cyclophosphamide; density functional theory; drug binding; lysozyme; spectroscopy

Mesh:

Substances:

Year:  2014        PMID: 25301295     DOI: 10.1080/07391102.2014.967299

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  1 in total

1.  Molecular dynamics simulation as a tool for assessment of drug binding property of human serum albumin.

Authors:  Meenu Narwal; Deepak Kumar; Tapan Kumar Mukherjee; Rajasri Bhattacharyya; Dibyajyoti Banerjee
Journal:  Mol Biol Rep       Date:  2018-08-18       Impact factor: 2.316

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.